Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.23.1
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Accrued liabilities:    
General and administrative $ 1,066 $ 855
Clinical trial related costs 2,023 1,327
Non-clinical research and manufacturing operations 1,182 1,779
Payroll related 1,243 4,828
Other accrued expenses 28 34
Total Accrued liabilities $ 5,542 $ 8,823